Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

cbdMD (YCBD) Return on Equity: 2017-2025

Historic Return on Equity for cbdMD (YCBD) over the last 9 years, with Sep 2025 value amounting to -0.44%.

  • cbdMD's Return on Equity rose 118.00% to -0.31% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.31%, marking a year-over-year increase of 118.00%. This contributed to the annual value of -0.44% for FY2025, which is 23.00% up from last year.
  • Latest data reveals that cbdMD reported Return on Equity of -0.44% as of FY2025, which was up 34.01% from -0.67% recorded in FY2024.
  • In the past 5 years, cbdMD's Return on Equity ranged from a high of -0.26% in FY2021 and a low of -1.13% during FY2023.
  • Its 3-year average for Return on Equity is -0.75%, with a median of -0.67% in 2024.
  • In the last 5 years, cbdMD's Return on Equity slumped by 78bps in 2022 and then surged by 46bps in 2024.
  • Yearly analysis of 5 years shows cbdMD's Return on Equity stood at -0.26% in 2021, then plummeted by 78bps to -1.04% in 2022, then decreased by 9bps to -1.13% in 2023, then soared by 46bps to -0.67% in 2024, then climbed by 23bps to -0.44% in 2025.